期刊文献+

非对称二甲基精氨酸与慢性肾脏病的进展

ADMA and progress of chronia kidney disease
原文传递
导出
摘要 非对称二甲基精氨酸(ADMA)是一种内源性一氧化氮合成酶(NOS)抑制剂,它可通过多种途径损伤内皮细胞,参与慢性肾脏病(CKD)的发生与发展。本文就ADMA的代谢与它在CKD中的作用作一综述。
出处 《国际泌尿系统杂志》 2020年第2期379-382,共4页 International Journal of Urology and Nephrology
  • 相关文献

参考文献3

二级参考文献18

  • 1Busch M, Fleck C, Wolf G, et al. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology? [J]. Amino Acids, 2006, 30 (3): 225 - 232.
  • 2Friedrich Schulzc, Henrike Lenzen, Christoph Hanefeld, et al. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the intlunce of ADMA Concentration (CARDIAC) study [J]. American Heart Journal, 2006, 152 (3): 493.
  • 3Francesca MaUamaci, Giovanni Tripepi, Renke Maas, et al. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end - stage renal disease [J]. J Am Soc Nephrol, 2004, 15 (2): 435-441.
  • 4Tran CT, Fox MF, Vallance P, et al. Chromosomal localization, gene structure, and expression pattern of DDAHI: comparison with DDAH2 and implications for evolutionary origins [ J ]. Genomics, 2000, 68 (1): 101-105.
  • 5Achan V, Broadhead M, Malaki M, et al. Asymmetric dimethylarginin causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimthy laminohydrolase [ J ]. Arterioscler Thromb Vasc Biol, 2003, 23 (8) : 1455 -1459.
  • 6Fleck C, Janz A, Schweitzer F, et al. Serum concentrations of asymmet tic (ADMA) andsymmetric (SDMA) dimethylarginine in renal failure patients [J]. Kidney Int Suppl, 2001, 78 (1) : 14 -18.
  • 7Lin KY, Ito A, Asagami T, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethyl arginine dimethylaminohydrolase [ J ]. Circulation, 2002, 106 (8) : 987 - 992.
  • 8Jan T, Kielstein, Rainer H, et al. Asymmetric dimethylarginine plasma concentrations differ in patients with end - stage renal disease: relationship to treatment method and atheroselerotic disease [J]. J Am Soc Nephrol, 1999, 10 (3): 594-600.
  • 9Bjorn Anderstam, Krassimir Katzatski, Jonas Bergstrom. Serum levels of NG, NG - dimethyl - L - arginine, a potential endogenous eitric oxide inhibitor in dialysis patinents [J]. J Am Soc Nephrol, 1997, 8 (9) : 1437 -1442.
  • 10Dominic SC, Brad Vincent, Keith Simepson, et al. Hemodynamic changs during hemodialysis : Role of nitric oxide and endothelin [ J ]. Kidney International, 2002, 61 (2): 697-704.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部